[Asia Economy Reporter Yoo Byung-don] Celltrion announced on the 10th that it has signed a supply contract worth 58.525 billion KRW with Celltrion Healthcare for Remsima IV, Truxima, and Herzuma.



This amount corresponds to 5.96% of recent sales revenue.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing